ASXL1 |
Q8IXJ9
|
ASXL transcriptional regulator 1
|
|
1.3E-14 |
0.482 |
0.808 |
BAP1 |
Q92560
|
BRCA1 associated protein 1
|
Enzyme
|
0.99 |
0.454 |
0.731 |
BRD4 |
O60885
|
bromodomain containing 4
|
Epigenetic regulator
|
1.00 |
0.446 |
0.885 |
CAP1 |
Q01518
|
cyclase associated actin cytoskeleton regulatory protein 1
|
Cellular structure
|
2.0E-02 |
0.529 |
0.808 |
CD274 |
Q9NZQ7
|
CD274 molecule
|
Receptor
|
1.9E-02 |
0.324 |
0.923 |
CD70 |
P32970
|
CD70 molecule
|
|
1.0E-02 |
0.542 |
0.692 |
CD74 |
P04233
|
CD74 molecule
|
Enzyme modulator
|
0.25 |
0.512 |
0.808 |
CDK2 |
P24941
|
cyclin dependent kinase 2
|
Kinase
|
0.61 |
0.456 |
0.692 |
CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
CFLAR |
O15519
|
CASP8 and FADD like apoptosis regulator
|
Enzyme
|
1.00 |
0.485 |
0.846 |
COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
CTAA1 |
|
cataract, anterior polar 1
|
|
|
0.568 |
0.731 |
CYLD |
Q9NQC7
|
CYLD lysine 63 deubiquitinase
|
Enzyme
|
1.00 |
0.498 |
0.846 |
DNMT3A |
Q9Y6K1
|
DNA methyltransferase 3 alpha
|
|
7.4E-39 |
0.445 |
0.846 |
DPYD |
Q12882
|
dihydropyrimidine dehydrogenase
|
Enzyme
|
3.4E-22 |
0.493 |
0.846 |
EGFR |
P00533
|
epidermal growth factor receptor
|
Kinase
|
0.37 |
0.295 |
0.885 |
FOXP3 |
Q9BZS1
|
forkhead box P3
|
|
0.99 |
0.368 |
0.846 |
GTF2I |
P78347
|
general transcription factor IIi
|
|
1.00 |
0.500 |
0.808 |
HACD1 |
B0YJ81
|
3-hydroxyacyl-CoA dehydratase 1
|
|
1.3E-09 |
0.539 |
0.846 |
HMGB1 |
P09429
|
high mobility group box 1
|
Nucleic acid binding
|
0.82 |
0.368 |
0.923 |
HPP1 |
|
hyperpigmentation, progressive, 1
|
|
|
0.686 |
0.346 |
HRAS |
P01112
|
HRas proto-oncogene, GTPase
|
Enzyme modulator
|
8.0E-02 |
0.378 |
0.885 |
IGF1 |
P05019
|
insulin like growth factor 1
|
|
0.27 |
0.318 |
0.885 |
KIT |
P10721
|
KIT proto-oncogene, receptor tyrosine kinase
|
Kinase
|
0.98 |
0.366 |
0.808 |
KRAS |
P01116
|
KRAS proto-oncogene, GTPase
|
Enzyme modulator
|
7.9E-04 |
0.320 |
0.923 |